Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joyce R Chong

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 30, 2023
Brain atrophy and white matter hyperintensities are independently associated with plasma neurofilament light chain in an Asian cohort of cognitively impaired patients with concomitant cerebral small vessel diseaseJoyce R Chong, Saima Hilal, Nicholas J Ashton, et al.
Journal of Alzheimer'S Disease : JAD|December 3, 2016
Increased Transforming Growth Factor β2 in the Neocortex of Alzheimer's Disease and Dementia with Lewy Bodies is Correlated with Disease Severity and Soluble Aβ42 LoadJoyce R Chong, Yuek Ling Chai, Jasinda H Lee, et al.
Journal of Neuroinflammation|May 9, 2023
Inflammatory panel cytokines are elevated in the neocortex of late-stage Alzheimer's disease but not Lewy body dementiasYuek Ling Chai, Jasinda H Lee, Joyce R Chong, et al.
Brain Pathology (Zurich, Switzerland)|July 28, 2018
Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degenerationYuek Ling Chai, Joyce R Chong, Jiaju Weng, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 12, 2024
Association of plasma GFAP with elevated brain amyloid is dependent on severity of white matter lesions in an Asian cognitively impaired cohortJoyce R Chong, Yuek Ling Chai, Amelia T Y Yam, et al.
Scientific Reports|February 18, 2021
Plasma osteopontin as a biomarker of Alzheimer's disease and vascular cognitive impairmentYuek Ling Chai, Joyce R Chong, Ainiah R Raquib, et al.
Biomolecules|January 23, 2024
Serum Brevican as a Biomarker of Cerebrovascular Disease in an Elderly Cognitively Impaired CohortRachel S L Chia, Karolina Minta, Liu-Yun Wu, et al.
Biomolecules|March 29, 2023
Elevated Soluble TNF-Receptor 1 in the Serum of Predementia Subjects with Cerebral Small Vessel DiseaseKaung H T Salai, Liu-Yun Wu, Joyce R Chong, et al.
Alzheimer'S Research & Therapy|January 28, 2026
Combining OCT and OCT angiography improves differentiation of mild cognitive impairment and Alzheimer's diseaseJacqueline Chua, Suman Singh, Shiyuan Gong, et al.
Communications Medicine|March 5, 2026
Spatial navigation as a digital marker for clinically differentiating cognitive impairment severityGiorgio Colombo, Karolina Minta, William R Taylor, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 30, 2023
Brain atrophy and white matter hyperintensities are independently associated with plasma neurofilament light chain in an Asian cohort of cognitively impaired patients with concomitant cerebral small vessel diseaseJoyce R Chong, Saima Hilal, Nicholas J Ashton, et al.
Journal of Alzheimer'S Disease : JAD|December 3, 2016
Increased Transforming Growth Factor β2 in the Neocortex of Alzheimer's Disease and Dementia with Lewy Bodies is Correlated with Disease Severity and Soluble Aβ42 LoadJoyce R Chong, Yuek Ling Chai, Jasinda H Lee, et al.
Journal of Neuroinflammation|May 9, 2023
Inflammatory panel cytokines are elevated in the neocortex of late-stage Alzheimer's disease but not Lewy body dementiasYuek Ling Chai, Jasinda H Lee, Joyce R Chong, et al.
Brain Pathology (Zurich, Switzerland)|July 28, 2018
Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degenerationYuek Ling Chai, Joyce R Chong, Jiaju Weng, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 12, 2024
Association of plasma GFAP with elevated brain amyloid is dependent on severity of white matter lesions in an Asian cognitively impaired cohortJoyce R Chong, Yuek Ling Chai, Amelia T Y Yam, et al.
Scientific Reports|February 18, 2021
Plasma osteopontin as a biomarker of Alzheimer's disease and vascular cognitive impairmentYuek Ling Chai, Joyce R Chong, Ainiah R Raquib, et al.
Biomolecules|January 23, 2024
Serum Brevican as a Biomarker of Cerebrovascular Disease in an Elderly Cognitively Impaired CohortRachel S L Chia, Karolina Minta, Liu-Yun Wu, et al.
Biomolecules|March 29, 2023
Elevated Soluble TNF-Receptor 1 in the Serum of Predementia Subjects with Cerebral Small Vessel DiseaseKaung H T Salai, Liu-Yun Wu, Joyce R Chong, et al.
Alzheimer'S Research & Therapy|January 28, 2026
Combining OCT and OCT angiography improves differentiation of mild cognitive impairment and Alzheimer's diseaseJacqueline Chua, Suman Singh, Shiyuan Gong, et al.
Communications Medicine|March 5, 2026
Spatial navigation as a digital marker for clinically differentiating cognitive impairment severityGiorgio Colombo, Karolina Minta, William R Taylor, et al.
Pageof 4